Pharmacologic Management of Osteoporosis
A total of 1.4 contact hours may be earned as CNE credit for reading “Pharmacologic Management of Osteoporosis” and for completing an online posttest and evaluation.
AWHONN is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
AWHONN holds a California BRN number, California CNE Provider #CEP580
The authors and planners for this activity report no conflict of interest or relevant financial relationships. The article includes no discussion of off-label drug or device use. No commercial support was received for this educational activity.
Osteoporosis is a serious health problem of endemic proportions in the United States. Approximately 50% of women will experience an osteoporosis-related fracture during their lifetimes. With the increase in the population of women age 65 and older, nurses need to be familiar with osteoporosis risks, prevention strategies, and screening guidelines to promote well-woman care. We provide an overview of the medications approved by the Food and Drug Administration (FDA) to treat and prevent osteoporosis.